CureVac AG: Today, we announced positive pre-clinical results at a low dose for our mRNA based lead vaccine candidate against the novel Coronavirus. We intend to initiate the first clinical trial in humans in June 2020.
Liveuamap is no longer providing historic data for previous years in free version
Buy one of our premium plans: Buy "PRO" from $7/month PRO account removes advertising, enables satellite maps, allowing to create own regions and opens additional features